Superficial Cervical Plexus Block for Pacemaker Insertion
NCT ID: NCT01473667
Last Updated: 2019-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
30 participants
INTERVENTIONAL
2011-11-30
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Superficial Cervical Plexus Block for IJCL Pain Management
NCT05252832
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine
NCT01788410
Ultrasound-guided Precise Superficial Cervical Plexus Block
NCT03695211
Superficial Cervical Plexus Block for Neck and Shoulder Pain
NCT03210181
RFD Versus Cervical Medial Branch Blocks in Chronic Degenerative Neck Pain
NCT01743326
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Superficial Cervical Plexus Block
Superficial Cervical Plexus Block (SCP) block
SCP block using 10-15ml of 1% Ropivacaine
Local Infiltration
Local site infiltration
Local site infiltration using 2% lidocaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Superficial Cervical Plexus Block (SCP) block
SCP block using 10-15ml of 1% Ropivacaine
Local site infiltration
Local site infiltration using 2% lidocaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Registered patients at Mayo Clinic in Florida scheduled to undergo primary insertion of pacemaker
Exclusion Criteria
* Sub-pectoral placement of pacemaker
* Patients with history of chronic pain
* Patients with anatomical abnormality or disruption to the pacemaker insertion site or site of block placement
* Patients with allergy to local anesthetic
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christopher B. Robards
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher Robards, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Jacksonville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-005969
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.